J&J’s IVD unit on the block – are GE and Danaher potential bidders?
This article was originally published in Clinica
Executive Summary
Rumors of Johnson & Johnson’s intention to cast off its Ortho Clinical Diagnostics unit picked up momentum following unconfirmed media reports that the healthcare giant has launched the sale process. Citing unnamed sources close to the matter, Reuters reported that J&J had hired JPMorgan Chase as bookkeepers for the deal, and that OCD – which has annual sales of $2bn – could fetch a hefty price tag of $5bn.